Clinical Trials Insight: 700027956

Trial Profile

Clinical Trials Insight: 700027956

Phase of Trial: Phase II

Latest Information Update: 30 Aug 2008

At a glance

  • Drugs Vorapaxar (Primary)
  • Indications Acute coronary syndromes
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 30 Aug 2008 Results were presented at the 2008 European Society of Cardiology meeting.
    • 30 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top